Amyloidosis – BJC TV https://tv.bjcardio.co.uk Short video updates for cardiologists Wed, 27 May 2026 10:50:07 +0000 en-GB hourly 1 https://wordpress.org/?v=7.0 https://tv.bjcardio.co.uk/wp-content/uploads/2023/06/cropped-favicon-32x32.png Amyloidosis – BJC TV https://tv.bjcardio.co.uk 32 32 Insights from the ESC Heart Failure Congress, 2026 https://tv.bjcardio.co.uk/cardiovascular-medicine/insights-from-the-esc-heart-failure-congress-2026/ Fri, 15 May 2026 14:02:25 +0000 https://tv.bjcardio.co.uk/?p=11734

Learn more about some of the key sessions from the conference:

Cardiac amyloidosis: early diagnosis matters

Controversies in contemporary drug therapy for heart failure

How to crack the cardiorenal code: from clinical mastery to unit creation

Advances in cardiomyopathies

Debate: artificial intelligence in heart failure care, a great equaliser or a new divider?

Speaker

Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospital Dorset

 

]]> What to expect when you visit the National Amyloidosis Centre https://tv.bjcardio.co.uk/featured-videos-1/what-to-expect-when-you-visit-the-national-amyloidosis-centre/ Thu, 23 Apr 2026 10:30:25 +0000 https://tv.bjcardio.co.uk/?p=11692 Key takeaways:
  • Early detection and accurate diagnosis are essential for optimising clinical management and improving outcomes in patients with amyloidosis
  • The National Amyloidosis Centre has a range of advanced diagnostic techniques to confirm the presence of amyloidosis in a person
  • Investigations may include SAP scintigraphy, cardiac MRI scans, DPD scans and genetic testing
  • Accurate subtyping enables tailored therapeutic strategies, which are key to effective disease management
Speakers

Emily Dixon, Principal Genetic Counsellor
Darren Foard, Lead AL Amyloidosis Clinical Nurse Specialist
Professor Philip Hawkins, Consultant Physician; Clinical Director; Founder of NAC
David Hutt, Lead Nuclear Medicine Technologist
Dr Ana Martinez Naharro, Consultant Cardiologist
Dr Tamer Rezk, Consultant Nephrologist
Dr Dorota Rowczenio, Head of Genetic Service
Angelique Smit, Lead Clinical and Research Nurse

]]> The National Amyloidosis Centre: A guide for clinicians https://tv.bjcardio.co.uk/featured-videos/the-national-amyloidosis-centre-a-guide-for-clinicians/ Thu, 23 Apr 2026 10:25:36 +0000 https://tv.bjcardio.co.uk/?p=11683 Key takeaways:
  • Early detection and diagnosis are key for improving outcomes in people with amyloidosis
  • There are 3 major types of amyloidosis seen at the NAC, each requiring specialised treatment
  • The NAC processes over 2500 cases of amyloidosis per year and offers a holistic approach to managing amyloidosis, including genetic counselling
Speakers

Christine Chiti, Clinical TTR Nurse Specialist
Emily Dixon, Principal Genetic Counsellor
Professor Marianna Fontana, Deputy Clinical and Research Lead
Janet Gilbertson, Head of Histology; Proteomic Service and Laboratory Manager
Professor Julian Gillmore, NAC Research Lead
Professor Philip Hawkins, Consultant Physician; Clinical Director; Founder of NAC
Dr Yousuf Razvi, Clinical Research Fellow
Angelique Smit, Lead Clinical and Research Nurse
Dr Tamer Rezk, Consultant Nephrologist
Professor Ashu Wechalekar, Laboratory Director and Consultant Haematologist
Dr Carol Whelan, Consultant Cardiologist

]]> Exploring cardiac amyloidosis: Diagnosis, treatment, and best practices https://tv.bjcardio.co.uk/cardiovascular-medicine/exploring-cardiac-amyloidosis-diagnosis-treatment-and-best-practices/ Tue, 31 Mar 2026 14:18:46 +0000 https://tv.bjcardio.co.uk/?p=10283 1 Clinical expert Dr Kate Gatenby highlights this and gives an overview of the causes, diagnosis and best practices in the management of patients with ATTR-CM.]]> Reference
  1. Bennani SY et al. Int J Cardiovasc Imaging 2016;32:1403–13

]]> Amyloidosis overview – prevalence, pathophysiology and treatment approaches https://tv.bjcardio.co.uk/featured-videos/amyloidosis-overview-prevalence-pathophysiology-and-treatment-approaches/ Fri, 24 Oct 2025 08:03:10 +0000 https://tv.bjcardio.co.uk/?p=10521 This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Amyloidosis is rapidly gaining recognition as a previously under-diagnosed cause of cardiomyopathy and heart failure. Here, experts from the National Amyloidosis Centre – the only centre in the UK specialising in the management of the condition – provide an overview of its prevalence, symptoms and key treatment principles.]]> Learning objectives
  • To understand the aetiology and key features of the most common forms of amyloidosis
  • To recognise the symptoms and signs that should prompt consideration of amyloidosis as a cause of cardiovascular symptoms
Speakers:

Professor Marianna Fontana Deputy Clinical and Research Lead
Dr Yousuf Razvi Clinical Research Fellow
Dr Dorota Rowczenio Head of Genetic Service
Angelique Smit Lead Clinical and Research Nurse
Professor Ashu Wechalekar Laboratory Director and Consultant Haematologist
Dr Carol Whelan Consultant Cardiologist

]]> Referral and diagnosis of suspected cardiac amyloidosis https://tv.bjcardio.co.uk/masterclass/referral-and-diagnosis-of-suspected-cardiac-amyloidosis/ Fri, 24 Oct 2025 08:02:35 +0000 https://tv.bjcardio.co.uk/?p=10536 This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Assessment of a patient with suspected amyloidosis requires a careful diagnostic workup, including cardiac imaging to identify amyloid infiltration in heart tissue that could lead to diastolic dysfunction and heart failure. In this Masterclass, clinicians and scientists from the National Amyloidosis Centre describe the laboratory tests and imaging techniques used to make an accurate diagnosis.]]> Learning objectives
  • To understand the imaging techniques used to diagnose and monitor cardiac amyloidosis, and the key features seen on these studies
  • To know all the information and test results that should be included in a referral for a patient suspected of having cardiac amyloidosis
  • To understand the role of genetic testing, immunohistochemistry and proteomics in the diagnostic pathway
Speakers:

Professor Marianna Fontana Deputy Clinical and Research Lead
Janet Gilbertson Head of Histology/Proteomic Service and Laboratory Manager
Professor Julian Gillmore NAC Research Lead
David Hutt Lead Nuclear Medicine Technologist
Dr Ana Martínez-Naharro Consultant Cardiologist
Dr Dorota Rowczenio Head of Genetic Service
Angelique Smit Lead Clinical and Research Nurse

]]> Signs and symptoms of amyloidosis – red flags for cardiologists https://tv.bjcardio.co.uk/masterclass/signs-and-symptoms-of-amyloidosis-red-flags-for-cardiologists/ Fri, 24 Oct 2025 08:01:47 +0000 https://tv.bjcardio.co.uk/?p=10544 This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Effective treatment of cardiac amyloidosis is dependent on early diagnosis; it is therefore important that clinicians have a high index of suspicion for the condition in their patients. Dr Josephine Mansell from the National Amyloidosis Centre outlines the “red flag” signs and symptoms that cardiologists, nurses or other healthcare professionals may observe in their patients, and which should prompt consideration of referral for a full diagnostic workup.]]> Learning objectives:
  • To recognise the signs and symptoms of transthyretin (ATTR) and light-chain (AL) amyloidosis
  • To understand which patients should be considered at risk of potentially having amyloidosis, and in whom these red flag symptoms should be assessed
Speakers:

Dr Josephine Mansell Clinical Research Fellow
Angelique Smit Lead Clinical and Research Nurse

]]>